Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 26691548)

Published in AIDS on January 01, 2016

Authors

Lesley S Park1, Raúl U Hernández-Ramírez, Michael J Silverberg, Kristina Crothers, Robert Dubrow

Author Affiliations

1: aDivision of Endocrinology, Gerontology, and Metabolism, Department of Medicine and Division of Epidemiology, Department of Health Policy and Research, Stanford University School of Medicine, Stanford, CaliforniabDepartment of Chronic Disease Epidemiology, Yale School of Public Health, Yale School of Medicine, New Haven, ConnecticutcDivision of Research, Kaiser Permanente, Oakland, CaliforniadDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Washington School of Medicine, Seattle, Washington, USA.*Lesley S. Park and Raúl U. Hernández-Ramírez contributed equally to this article.

Articles citing this

Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res (2016) 0.83

Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS (2017) 0.83

Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. AIDS (2016) 0.82

Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr (2016) 0.79

Aging metabolism: intervention strategies. Virulence (2017) 0.78

Smoking Status and Opioid Related Problems and Concerns among Men and Women on Chronic Opioid Therapy. Clin J Pain (2016) 0.77

Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients. J Acquir Immune Defic Syndr (2016) 0.77

Tobacco and alcohol use among drug users receiving methadone maintenance treatment: a cross-sectional study in a rural prefecture of Yunnan Province, Southwest China. BMJ Open (2017) 0.75

Lung cancer in persons with HIV. Curr Opin HIV AIDS (2017) 0.75

Human immunodeficiency virus and acquired immunodeficiency syndrome: recent developments and their implications for pediatric surgeons. Semin Pediatr Surg (1995) 0.75

HIV and ageing: improving quantity and quality of life. Curr Opin HIV AIDS (2016) 0.75

Sex Differences in Tobacco Use Among Persons Living With HIV/AIDS: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr (2017) 0.75

Integrating HIV and substance use services: a systematic review. J Int AIDS Soc (2017) 0.75

Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results. Contemp Clin Trials (2017) 0.75

Articles cited by this

(truncated to the top 100)

Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24

Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58

Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep (2009) 11.30

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21

Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology (2012) 10.00

Prevalence of oral HPV infection in the United States, 2009-2010. JAMA (2012) 6.02

HIV infection and the risk of acute myocardial infarction. JAMA Intern Med (2013) 5.90

Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69

Interpretation of random effects meta-analyses. BMJ (2011) 4.32

HIV surveillance--United States, 1981-2008. MMWR Morb Mortal Wkly Rep (2011) 4.30

Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis (2010) 3.79

Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS (2006) 3.76

A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76

Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet (2014) 3.31

Smoking and colorectal cancer: a meta-analysis. JAMA (2008) 3.19

Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. JAMA (2015) 3.14

Alcohol and cancer. Lancet Oncol (2006) 3.10

Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med (2011) 2.94

Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88

Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. J Infect Dis (2011) 2.86

Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63

Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation (2012) 2.59

Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial. JAMA (2015) 2.58

Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol (2012) 2.29

Moving forward in HIV-associated cancer. J Clin Oncol (2014) 2.14

Meta-analysis of prevalence. J Epidemiol Community Health (2013) 2.03

Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis (2011) 1.83

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med (2012) 1.76

Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men. Sex Transm Dis (2012) 1.74

The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol (2013) 1.69

Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS (2008) 1.69

Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev (2011) 1.68

The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS (2011) 1.65

Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS (2009) 1.64

Biology of HPV in HIV infection. Adv Dent Res (2006) 1.61

Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health (2014) 1.58

Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57

Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics (2010) 1.57

State-specific prevalence of cigarette smoking among adults and quitting among persons aged 18-35 years--United States, 2006. MMWR Morb Mortal Wkly Rep (2007) 1.49

Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics (2009) 1.48

Use of the Alcohol Use Disorders Identification Test (AUDIT) to determine the prevalence of alcohol misuse among HIV-infected individuals. Int J STD AIDS (2013) 1.46

Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011. BJOG (2013) 1.44

Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS (2014) 1.41

Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 1.37

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis (2010) 1.37

Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep (2012) 1.36

Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res (2010) 1.30

Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr (2012) 1.30

Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst (2013) 1.29

Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol (2008) 1.29

Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One (2012) 1.28

Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav (2010) 1.27

Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS (2014) 1.27

B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer (2004) 1.26

Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J (2010) 1.25

Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infect Dis (2011) 1.23

Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther (2012) 1.22

Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21

Fractures after antiretroviral initiation. AIDS (2012) 1.21

Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men. Sex Transm Dis (2013) 1.20

Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study. AIDS Patient Care STDS (2009) 1.17

Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc (2011) 1.15

Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Res Hum Retroviruses (2012) 1.13

The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. J Viral Hepat (2010) 1.11

Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis (2012) 1.11

Seroprevalence of HIV in the US Household Population Aged 18–49 Years: The National Health and Nutrition Examination Surveys, 1999–2006. J Acquir Immune Defic Syndr (2010) 1.11

HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol (2012) 1.10

Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection (2012) 1.10

InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst (2012) 1.09

Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clin Infect Dis (2012) 1.08

B-cell subset alterations and correlated factors in HIV-1 infection. AIDS (2013) 1.08

Alcohol use, anal sex, and other risky sexual behaviors among HIV-infected women and men. AIDS Behav (2013) 1.07

Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clin Infect Dis (2014) 1.06

Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis (2012) 1.05

Substance use and the quality of patient-provider communication in HIV clinics. AIDS Behav (2011) 1.05

Patterns of substance use among a large urban cohort of HIV-infected men who have sex with men in primary care. AIDS Behav (2012) 1.05

Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis (2013) 1.05

Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy. Eur J Epidemiol (2012) 1.05

Assessment of factors influencing health-related quality of life in HIV-infected patients. HIV Med (2011) 1.04

Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev (2012) 1.04

Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals. J Acquir Immune Defic Syndr (2012) 1.03

Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents. J Viral Hepat (2011) 1.02

Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections. J Acquir Immune Defic Syndr (2013) 1.02

Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav (2013) 1.02

HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst (2013) 1.02

High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010. J Infect Dis (2014) 1.01

Comparing alcohol screening measures among HIV-infected and -uninfected men. Alcohol Clin Exp Res (2012) 1.01

The clinical implications of high rates of intimate partner violence against HIV-positive women. J Acquir Immune Defic Syndr (2013) 1.01

Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis (2013) 0.99

Hepatitis C infection among men who have sex with men, San Francisco, 2011. Sex Transm Dis (2012) 0.99

Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy. AIDS Res Hum Retroviruses (2013) 0.98

Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.98

Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDS (2011) 0.98

Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study. BMC Infect Dis (2011) 0.97

Articles by these authors

Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90

Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med (2010) 11.99

HIV infection and the risk of acute myocardial infarction. JAMA Intern Med (2013) 5.90

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS (2008) 5.30

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst (2005) 5.29

De facto long-term opioid therapy for noncancer pain. Clin J Pain (2008) 3.85

Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72

Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65

Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf (2009) 3.25

Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07

African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer (2004) 2.96

Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care (2006) 2.82

Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50

Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med (2007) 2.38

Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health (2010) 2.13

Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain (2009) 2.09

Carbonated soft drink consumption and risk of esophageal adenocarcinoma. J Natl Cancer Inst (2006) 2.08

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05

Behavior change following diagnosis with acute/early HIV infection-a move to serosorting with other HIV-infected individuals. The NIMH Multisite Acute HIV Infection Study: III. AIDS Behav (2009) 2.03

HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.02

Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94

Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA (2005) 1.86

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86

Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry (2009) 1.84

HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis (2012) 1.83

Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS Patient Care STDS (2009) 1.78

Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr (2013) 1.73

Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med (2013) 1.71

Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res (2011) 1.69

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med (2014) 1.64

Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis (2008) 1.62

Personal care product use and urinary levels of phthalate metabolites in Mexican women. Environ Int (2011) 1.56

Prevalence and contexts of inconsistent condom use among heterosexual men and women living with HIV in India: implications for prevention. AIDS Patient Care STDS (2010) 1.55

HIV as an independent risk factor for incident lung cancer. AIDS (2012) 1.54

Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J Immunol (2005) 1.53

Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev (2008) 1.51

Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer (2011) 1.50

Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States. AIDS Patient Care STDS (2013) 1.43

Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS (2011) 1.37

Lack of understanding of acute HIV infection among newly-infected persons-implications for prevention and public health: The NIMH Multisite Acute HIV Infection Study: II. AIDS Behav (2009) 1.37

Virologic and immunologic response to HAART, by age and regimen class. AIDS (2010) 1.34

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS (2013) 1.34

Exposure to phthalates and breast cancer risk in northern Mexico. Environ Health Perspect (2010) 1.30

Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol (2004) 1.30

Lessons learned about behavioral science and acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: V. AIDS Behav (2009) 1.26

Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I. AIDS Behav (2009) 1.26

Height, body mass index, and physical activity in relation to glioma risk. Cancer Res (2009) 1.25

Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr (2013) 1.23

Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort study. AIDS Behav (2007) 1.23

Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India. AIDS Care (2013) 1.21

The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med (2006) 1.21

Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol (2005) 1.21

Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep (2011) 1.21

Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV. AIDS Behav (2009) 1.20

HIV-associated opportunistic pneumonias. Respirology (2009) 1.19

HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc (2011) 1.18

Phthalate exposure associated with self-reported diabetes among Mexican women. Environ Res (2011) 1.18

Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer (2008) 1.17

Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr (2015) 1.17

State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. Proc Am Thorac Soc (2006) 1.16

HIV infection and incidence of ischemic stroke. AIDS (2014) 1.15

A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis (2004) 1.15

Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg Infect Dis (2004) 1.14

CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther (2010) 1.13

Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis (2011) 1.11

HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol (2012) 1.10

The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev (2012) 1.10

Social-structural contexts of needle and syringe sharing behaviours of HIV-positive injecting drug users in Manipur, India: a mixed methods investigation. Harm Reduct J (2011) 1.09

The changing epidemiology of HIV-infected patients in the intensive care unit. J Intensive Care Med (2011) 1.08

Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California. Sex Transm Dis (2010) 1.07

Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS (2012) 1.07

Antibody response to Pneumocystis jirovecii major surface glycoprotein. Emerg Infect Dis (2006) 1.06

Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer. Ann Epidemiol (2011) 1.06

Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis (2014) 1.06

Pneumocystis colonization in HIV-infected patients. J Eukaryot Microbiol (2003) 1.06

Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr (2016) 1.05

Barriers to free antiretroviral treatment access among kothi-identified men who have sex with men and aravanis (transgender women) in Chennai, India. AIDS Care (2011) 1.04

The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr (2012) 1.03

International variation in the incidence of adult primary malignant neoplasms of the brain and central nervous system. Cancer Causes Control (2009) 1.02

Association between smoking and latent tuberculosis in the U.S. population: an analysis of the National Health and Nutrition Examination Survey. PLoS One (2012) 1.01

Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest (2014) 1.00

FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients. Cancer Epidemiol Biomarkers Prev (2011) 1.00

Prevalence of and barriers to dual-contraceptive methods use among married men and women living with HIV in India. Infect Dis Obstet Gynecol (2011) 0.98

HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS (2011) 0.98

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. J Infect Dis (2013) 0.97

Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr (2012) 0.96

Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma. Clin Cancer Res (2012) 0.96

Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci (2012) 0.95

Using modeling to inform patient-centered care choices at the end of life. J Comp Eff Res (2013) 0.95

Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr (2014) 0.94

Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study. Cancer Epidemiol Biomarkers Prev (2004) 0.94

Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk. Curr Opin HIV AIDS (2014) 0.93

Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. J Acquir Immune Defic Syndr (2016) 0.93